A
AREV Life Sciences Global Corp
CNSX:AREV
AREV Life Sciences Global Corp
CNSX:AREV
Price:
0.09
CAD
Market Closed
Market Cap:
CA$2.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
AREV Life Sciences Global Corp
CNSX:AREV
|
CA |
|
Liberty Global PLC
NASDAQ:LBTYA
|
UK |
|
H
|
Hangzhou Lion Electronics Co Ltd
SSE:605358
|
CN |
|
A
|
Agilyx ASA
OSE:AGLX
|
NO |
|
Matsuya Foods Holdings Co Ltd
TSE:9887
|
JP |
|
Grand Vision Media Holdings PLC
LSE:GVMH
|
UK |
|
Xinyi Glass Holdings Ltd
HKEX:868
|
HK |
|
J
|
Jiangsu Favored Nanotechnology Co Ltd
SSE:688371
|
CN |
|
Lithium South Development Corp
XTSX:LIS
|
CA |
|
LifeTech Scientific Corp
HKEX:1302
|
CN |
|
Sadhana Nitro Chem Ltd
BSE:506642
|
IN |
|
S
|
Shanghai Beite Technology Co Ltd
SSE:603009
|
CN |
|
W
|
Winfarm SA
PAR:ALWF
|
FR |
|
biOasis Technologies Inc
XTSX:BTI
|
CA |
|
SingSong Holdings Co Ltd
KRX:006880
|
KR |
|
P
|
PCCS Group Bhd
KLSE:PCCS
|
MY |
|
Nila Spaces Ltd
NSE:NILASPACES
|
IN |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of AREV.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
AREV
Multiples-Based Value
Base Case
Not Available
Multiples Across Competitors
AREV Competitors Multiples
AREV Life Sciences Global Corp Competitors
AREV Life Sciences Global Corp Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CA |
A
|
AREV Life Sciences Global Corp
CNSX:AREV
|
2.9m CAD | 0 | -9 | -8.1 | -9.5 | |
| US |
G
|
GE Vernova LLC
NYSE:GEV
|
230B USD | 0 | 0 | 0 | 0 | |
| UK |
E
|
Eight Capital Partners PLC
F:ECS
|
158.4B EUR | 0 | 0 | 0 | 0 | |
| US |
C
|
China Industrial Group Inc
OTC:CIND
|
121B USD | 351.6 | 4 020.7 | 3 417.4 | 3 537.2 | |
| NL |
N
|
Nepi Rockcastle NV
JSE:NRP
|
97.4B ZAR | 5.6 | 10.4 | 14.2 | 14.3 | |
| CH |
G
|
Galderma Group AG
SIX:GALD
|
35.5B CHF | 0 | 0 | 0 | 0 | |
| US |
I
|
Inspire Veterinary Partners Inc
NASDAQ:IVP
|
38.9B USD | 2 500.8 | -3 258.5 | -5 033.1 | -4 340.4 | |
| US |
C
|
CoreWeave Inc
NASDAQ:CRWV
|
37.6B USD | 0 | 0 | 0 | 0 | |
| US |
|
Coupang Inc
F:788
|
29.4B EUR | 0.9 | 156.5 | 28.1 | 58.9 | |
| US |
|
Symbotic Inc
NASDAQ:SYM
|
30.4B USD | 12.7 | -2 788.5 | -3 656.4 | -587.5 | |
| ZA |
F
|
Fortress Real Estate Investments Ltd
JSE:FFB
|
28.3B ZAR | 4.5 | 8.2 | 11.4 | 11.4 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
